{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:22Z","timestamp":1791233062689,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.prp.2022.153942","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:03:15Z","timestamp":1652479395000},"page":"153942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dysplastic nevi and melanoma: microRNAs tell a divergent story"],"prefix":"10.1016","volume":"235","author":[{"given":"Giorgio","family":"Durante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Misciali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Riefolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Tartari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Dika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prp.2022.153942_bib1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial malignant melanomas from heritable melanocytic lesions. \u2018The B-K mole syndrome\u2019","volume":"114","author":"Clark","year":"1978","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib2","first-page":"85","article-title":"Precursor lesions in familial melanoma","volume":"5","author":"Greene","year":"1978","journal-title":"Semin Oncol."},{"issue":"8","key":"10.1016\/j.prp.2022.153942_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jama.1978.03280350068019","article-title":"Precursor lesions in familial melanoma. a new genetic preneoplastic syndrome","volume":"239","author":"Reimer","year":"1978","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.prp.2022.153942_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.1988.tb02036.x","article-title":"What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? a riddle and an answer","volume":"13","author":"Ackerman","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2022.153942_bib5","doi-asserted-by":"crossref","unstructured":"NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA. 1992;268(10):1314\u20131319.","DOI":"10.1001\/jama.1992.03490100112037"},{"key":"10.1016\/j.prp.2022.153942_bib6","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27\u201329, 1992. Am J Dermatopathol. 1993;15(1):34\u201343; discussion 46\u201351.","DOI":"10.1097\/00000372-199302000-00006"},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00000372-199302000-00007","article-title":"What is early melanoma?","volume":"15","author":"Kopf","year":"1993","journal-title":"Am. J. Derm."},{"key":"10.1016\/j.prp.2022.153942_bib8","doi-asserted-by":"crossref","unstructured":"Ackerman AB. A critique of an N.I.H. Consensus Development Conference about \"early\" melanoma. Am J Dermatopathol. 1993;15(1):52\u201358.","DOI":"10.1097\/00000372-199302000-00010"},{"issue":"4","key":"10.1016\/j.prp.2022.153942_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.0303-6987.2005.0315a.x","article-title":"War and peace in the realm of dysplastic nevi","volume":"32","author":"Cramer","year":"2005","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2022.153942_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10689-016-9888-2","article-title":"Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity","volume":"15","author":"Lynch","year":"2016","journal-title":"Fam. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2022.153942_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.1994.01690080065008","article-title":"Melanoma risk in individuals with clinically atypical nevi","volume":"130","author":"Kang","year":"1994","journal-title":"Arch. Dermatol."},{"issue":"20","key":"10.1016\/j.prp.2022.153942_bib13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prp.2022.153942_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2022.153942_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0303-6987.2005.00354.x","article-title":"The melanocytic nevus described by Clark et al. what is its nature? what should it be named? an answer from history and from logic","volume":"32","author":"Hurt","year":"2005","journal-title":"J. Cutan. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2022.153942_bib16","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.24899","article-title":"Altered molecular pathways in melanocytic lesions","volume":"126","author":"Scatolini","year":"2010","journal-title":"Int J. Cancer"},{"issue":"6892","key":"10.1016\/j.prp.2022.153942_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.prp.2022.153942_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.prp.2022.153942_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/DAD.0b013e3181584950","article-title":"Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis","volume":"29","author":"Wu","year":"2007","journal-title":"Am. J. Derm."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.jid.5700011","article-title":"Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi","volume":"126","author":"Uribe","year":"2006","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.jid.5700490","article-title":"Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations","volume":"127","author":"Bauer","year":"2007","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.prp.2022.153942_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.2.e14","article-title":"Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi","volume":"40","author":"Papp","year":"2003","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.prp.2022.153942_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00008390-200510000-00008","article-title":"Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi","volume":"15","author":"Papp","year":"2005","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1878-0261.12412","article-title":"Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces","volume":"13","author":"Riefolo","year":"2019","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jid.2019.06.126","article-title":"MicroRNA ratios distinguish melanomas from nevi","volume":"140","author":"Torres","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"11","key":"10.1016\/j.prp.2022.153942_bib27","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jid.2020.03.949","article-title":"Defining the prognostic role of MicroRNAs in cutaneous melanoma","volume":"140","author":"Dika","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.prp.2022.153942_bib28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1586\/14737159.2015.1081058","article-title":"Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis","volume":"15","author":"Ferracin","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.prp.2022.153942_bib29","unstructured":"Andrews S. FASTQC. A quality control tool for high throughput sequence data. 2010."},{"key":"10.1016\/j.prp.2022.153942_bib30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","article-title":"ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R","volume":"35","author":"Paradis","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2022.153942_bib31","unstructured":"Team RC. R.: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013."},{"issue":"3","key":"10.1016\/j.prp.2022.153942_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaad.2015.04.029","article-title":"Dysplastic nevus: fact and fiction","volume":"73","author":"Rosendahl","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2022.153942_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2012.02.047","article-title":"The dysplastic nevus: from historical perspective to management in the modern era: part II. molecular aspects and clinical management","volume":"67","author":"Duffy","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2022.153942_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2340\/00015555-2908","article-title":"Dysplastic vs. common naevus-associated vs. de novo melanomas: an observational retrospective study of 1,021 patients","volume":"98","author":"Martin-Gorgojo","year":"2018","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.prp.2022.153942_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1346-8138.14737","article-title":"Histogenesis of cutaneous malignant melanoma: the vast majority do not develop from melanocytic nevus but arise de novo as melanoma in situ","volume":"46","author":"Saida","year":"2019","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2022.153942_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1006\/bbrc.1997.7212","article-title":"Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus","volume":"237","author":"Lee","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:51:08Z","timestamp":1759733468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822001868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"alternative-id":["S0344033822001868"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153942","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysplastic nevi and melanoma: microRNAs tell a divergent story","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153942"}}